Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 238

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Disease severity dictates SARS-CoV-2-specific neutralizing antibody responses in COVID-19

Open access
Chen, Xiangyu, Pan, Zhiwei, Yue, Shuai, Yu, Fei, Zhang, Junsong, Yang, Yang, Li, Ren, Liu, Bingfeng, Yang, Xiaofan, Gao, Leiqiong, Li, Zhirong, Lin, Yao, Huang, Qizhao, Xu, Lifan, Tang, Jianfang, Hu, Li, Zhao, Jing, Liu, Pinghuang, Zhang, Guozhong, Chen, Yaokai, Deng, Kai, Ye, Lilin · 2020 · Signal Transduction and Targeted Therapy

Abstract

COVID-19 patients exhibit differential disease severity after SARS-CoV-2 infection. It is currently unknown as to the correlation between the magnitude of neutralizing antibody (NAb) responses and the disease severity in COVID-19 patients. In a cohort of 59 recovered patients with disease severity including severe, moderate, mild, and asymptomatic, we observed the positive correlation between serum neutralizing capacity and disease severity, in particular, the highest NAb capacity in sera from the patients with severe disease, while a lack of ability of asymptomatic patients to mount competent NAbs. Furthermore, the compositions of NAb subtypes were also different between recovered patients with severe symptoms and with mild-to-moderate symptoms. These results reveal the tremendous heterogeneity of SARS-CoV-2-specific NAb responses and their correlations to disease severity, highlighting the needs of future vaccination in COVID-19 patients recovered from asymptomatic or mild illness.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41392-020-00301-9

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 16 references

Cited by

See all 238

Metadata

Authors
Chen, X., Pan, Z., Yue, S., Yu, F., Zhang, J., Yang, Y., Li, R., Liu, B., Yang, X., Gao, L., Li, Z., Lin, Y., Huang, Q., Xu, L., Tang, J., Hu, L., Zhao, J., Liu, P., Zhang, G., Chen, Y., Deng, K., & Ye, L.
Venue
Signal Transduction and Targeted Therapy
Published
2020-09-02
Volume
5
Issue
1
Pages
180-180
ISSN
2059-3635 (ISSN-L)
OpenAlex
W3082162733
Cited by
238
References
16
FWCI
6.25
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Disease severity dictates SARS-CoV-2-specific neutralizing antibody responses in COVID-19. https://app.cochat.ai/papers/10.1038/s41392-020-00301-9
The paper
Chen, X., Pan, Z., Yue, S., Yu, F., Zhang, J., Yang, Y., Li, R., Liu, B., Yang, X., Gao, L., Li, Z., Lin, Y., Huang, Q., Xu, L., Tang, J., Hu, L., Zhao, J., Liu, P., Zhang, G., . . . Ye, L. (2020). Disease severity dictates SARS-CoV-2-specific neutralizing antibody responses in COVID-19. Signal Transduction and Targeted Therapy. https://doi.org/10.1038/s41392-020-00301-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.